Company: WHWK
Filing Date: 2025-01-21
Form Type: PREM14A
Source: 0001193125-25-009599
Chunk: 430

Company: Whitehawk Therapeutics, Inc.
Filing Date: 2025-01-21
Form: PREM14A
Chunk 430
---
 if the breadth or strength of protection provided by our patents and patent applications or the patents and patent applications of our licensors is threatened, regardless of the outcome, it could dissuade companies from collaborating with us to license, develop or commercialize current or future products or product candidates. If any of our patents, if and when issued, covering our product candidates are invalidated or found unenforceable, our financial position and results of operations would be materially and adversely impacted. We may not prevail in any lawsuits that we or any third-party initiate and the damages or other remedies awarded if we were to prevail may not be commercially meaningful. Intellectual property rights do not necessarily address all potential threats to our competitive advantage. The degree of future protection afforded by our intellectual property rights is uncertain because intellectual property rights have limitations and may not adequately protect our business or permit us to maintain our competitive advantage. For example:

| • |     | others may be able to develop products that are similar to FYARRO or any future product candidates but that are 
 not covered by the claims of the patents that we own or license;                                                |

| • |     | we or our licensors or collaborators might not have been the first to make the inventions covered by the issued 
 patents or patent application that we own or license;                                                           |

| • |     | we or our licensors or collaborators might not have been the first to file patent applications covering certain 
 of our inventions;                                                                                              |

| • |     | others may independently develop similar or alternative technologies or duplicate any of our technologies without 
 infringing our intellectual property rights;                                                                      |

| • |     | it is possible that the pending patent applications we own or license will not lead to issued patents; |

- 289 -

| • |     | issued patents that we own or license may be held invalid or unenforceable, as a result of legal challenges by 
 our competitors;                                                                                               |

| • |     | our competitors might conduct research and development activities in countries where we do not have patent rights                   
 and then use the information learned from such activities to develop competitive products for sale in our major commercial markets; |

| • |     | we may not develop additional proprietary technologies that are patentable; |

| • |     | the patents of others may have an adverse effect on our business; and |

| • |     | we may choose not to file a patent in order to maintain certain trade secrets or                
 know-how, and a third party may subsequently file a patent covering such intellectual property. |

Should any